Publications by authors named "Daniel P Wermeling"

Claim this Profile
R
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.
Daniel P Wermeling

Ther Adv Drug Saf· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal naloxone administration for treatment of opioid overdose.
Amanda Robinson, Daniel P Wermeling

Am J Health Syst Pharm· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.
Abby M Bailey, Daniel P Wermeling

Ann Pharmacother· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of naloxone legal status in opioid overdose prevention and treatment.
Leanne Hewlett, Daniel P Wermeling

J Opioid Manag· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A response to the opioid overdose epidemic: naloxone nasal spray.
Daniel P Wermeling

Drug Deliv Transl Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitis.
George A Davis, Anita C Rudy, Sanford M Archer, Daniel P Wermeling, Patrick J McNamara

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.
Joshua A Lile, Shanna Babalonis, Cleeve Emurian, Catherine A Martin, Daniel P Wermeling

J Clin Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid harm reduction strategies: focus on expanded access to intranasal naloxone.
Daniel P Wermeling

Pharmacotherapy· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury.
Daniel P Wermeling, Thomas Clinch, Anita C Rudy, David Dreitlein, Selim Suner

J Pain· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal delivery of antiepileptic medications for treatment of seizures.
Daniel P Wermeling

Neurotherapeutics· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.
Daniel P Wermeling, Kenneth A Record, Sanford M Archer, Anita C Rudy

Epilepsy Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study.
Jodi L Miller, J Wesson Ashford, Sanford M Archer, Anita C Rudy, Daniel P Wermeling

Pharmacotherapy· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microneedles permit transdermal delivery of a skin-impermeant medication to humans.
Daniel P Wermeling, Stan L Banks, David A Hudson, Harvinder S Gill, Jyoti Gupta

Proc Natl Acad Sci U S A· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal absorption of Delta(9)-tetrahydrocannabinol and WIN55,212-2 mesylate in rats.
Satyanarayana Valiveti, Remigius U Agu, Dana C Hammell, Kalpana S Paudel, D Caroline Earles, Daniel P Wermeling

Eur J Pharm Biopharm· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
Daniel P Wermeling, Kenneth A Record, Thomas H Kelly, Sanford M Archer, Thomas Clinch

Anesth Analg· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.
Daniel P Wermeling, Joseph R Berger

Pharmacotherapy· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, bioequivalence, and spray weight reproducibility of intranasal butorphanol after administration with 2 different nasal spray pumps.
Daniel P Wermeling, Jodi L Miller, Sanford M Archer, Mary K Rayens, Anita C Rudy

J Clin Pharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
Daniel P Wermeling

Pharmacotherapy· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
Daniel P Wermeling, George M Grant, Allen Lee, Nicole Alexander, Anita C Rudy

Clin Ther· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability of intranasal butorphanol administered from a single-dose sprayer.
George A Davis, Ani Ia C Rudy, Sanford M Archer, Daniel P Wermeling

Am J Health Syst Pharm· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers.
Anita C Rudy, Barbara A Coda, Sanford M Archer, Daniel P Wermeling

Anesth Analg· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats.
Remigius U Agu, Satyanarayana Valiveti, D Caroline Earles, Mitchell Klausner, Patrick J Hayden, Daniel P Wermeling

Endocr Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayer.
George A Davis, Anita C Rudy, Sanford M Archer, Daniel P Wermeling

Am J Health Syst Pharm· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
George A Davis, Anita C Rudy, Sanford M Archer, Daniel P Wermeling, Patrick J McNamara

Pharmacotherapy· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
Barbara A Coda, Anita C Rudy, Sanford M Archer, Daniel P Wermeling

Anesth Analg· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis